Trial · NCT01998113
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 30
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 3rd trimester glycated hemoglobin | 3rd trimester of pregnancy | mean difference of 3rd trimester glycated hemoglobin |
| Primary | total maternal weight gain | during pregnancy | mean difference of total maternal weight gain (as defined by the authors) |
| Primary | severe maternal hypoglycemia | from enrollment to delivery | relative risk of severe maternal hypoglycemia (as defined by the authors) |
| Primary | preeclampsia | during pregnancy or puerperium | relative risk of preeclampsia (as defined by the authors) |
| Primary | cesarean section | at the end of pregnancy | relative risk of cesarean section (as defined by the authors) |
| Primary | gestational age at birth | at birth | mean difference of gestational age at birth (as defined by the authors) |
| Primary | preterm birth | at birth | relative risk of preterm birth (as defined by the authors) |
| Primary | birthweight | at birth | mean difference of birthweight (as defined by the authors) |
| Primary | macrosomia | at birth | relative risk of macrosomia (defined as birthweight \>=4000 g) |
| Primary | large-for-gestational age newborn | at birth | relative risk of large-for-gestational age newborn (as defined by the authors) |
| Primary | small-for-gestational age newborn | at birth | relative risk of small-for-gestational age newborn (as defined by the authors) |
| Primary | neonatal hypoglycemia | in the neonatal period | relative risk of neonatal hypoglycemia (as provided by the authors) |
| Primary | perinatal mortality | in the perinatal period | relative risk of perinatal mortality (as defined by the authors) |
| Primary | insulin treatment | from enrollment to delivery | relative risk of insulin treatment (for trials comparing metformin vs glyburide) |
| Secondary | fasting blood glucose | in the period from enrollment to delivery | mean difference of fasting blood glucose (as defined by the authors) |
| Secondary | postprandial blood glucose | in the period from enrollment to delivery | mean difference of postprandial blood glucose (as defined by the authors) |
| Secondary | maternal weight gain since enrollment | in the period from enrollment to delivery | mean difference of maternal weight gain since enrollment (as defined by the authors) |
| Secondary | pregnancy-induced hypertension | during pregnancy | relative risk of pregnancy-induced hypertension (as defined by the authors) |
| Secondary | induction of labour | at the end of pregnancy | relative risk of induction of labour (as described by the authors) |
| Secondary | cord C peptide | at birth | mean difference of cord C peptide (as defined by the authors) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01998113/registered